Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neuroma, Acoustic 1 Neurofibromatosis 2 1

Interventions

Everolimus 3 Bevacizumab 3 Lapatinib 2 vistusertib 1 icotinib 1 Vascular Endothelial Growth Factor A 1 Sunitinib 1 Sirolimus 1 Magnetic Resonance Imaging 1 Exome 1 Endostatins 1 Crizotinib 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neurofibromatosis 2 × Exome × Clear all

NCT03210285 2018-07-23

NF2

University Hospital Tuebingen

Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡